Published On: 4/25/2025
How does causalStudio™ address the key regulatory requirements for data integrity, traceability, and analysis?
Welcome back to Target RWE’s Behind the Data series! In this episode, McKinley Peter, Digital Marketing Specialist at Target RWE, is joined once again by Dr. David Pritchard, Director of Data Management and Statistics, for a deeper dive into causalStudio™—Target RWE’s innovative platform designed to advance real-world data analysis. Building on their last conversation, today’s discussion explores how the integrated tools causalRisk™ and causalPHR™ work together to meet regulatory demands for data integrity and traceability, while also providing flexible, user-friendly solutions for analyzing and visualizing data from diverse sources.
Ready to see how causalStudio™ is transforming real-world evidence generation? Watch the full interview now to discover how causalRisk™ and causalPHR™ work together to deliver regulatory-grade insights with clarity and confidence.
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
McKinley Peter
Digital Marketing Specialist
+1 (352) 514-8045
More News
-
05/09/2025
Target RWE at EASL 2025: Advancing HCC, MASH & PBC Research -
05/08/2025
EASL 2025 Research: Presentation by Michael Roden, MD -
04/25/2025
How does causalStudio™ address the key regulatory requirements for data integrity, traceability, and analysis? -
04/03/2025
An Overview of MASH: Advancements in Diagnosis, Treatment, and the Role of Real-World Data -
03/31/2025
Addressing the Burden of Hidradenitis Suppurativa: The Often-Hidden Impact on Quality of Life